PRAMETAG
Live / Registered — Registered (as of 13 Jan 2026)
What this means for you
Registered since 13 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98405696
- Registration number
- 8098316
- Mark type
- Stylized text
- Filed
- 14 Feb 2024
- Published for opposition
- 25 Nov 2025
- Registered
- 13 Jan 2026
- Attorney of record
- Andrew D. Price & Paula E. Hopkins
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
Owner
- Immunocore Limited, Oxfordshire, GB
- Immunocore Limited, Oxfordshire, GB
- Immunocore Limited, Oxfordshire, GB
Prosecution history
- 13 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Oct 2025 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 27 Oct 2025 — CASE RETURNED TO EXAMINATION
- 27 Oct 2025 — NOTICE OF ALLOWANCE CANCELLED
- 24 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2025 — SOU EXTENSION 1 GRANTED
- 23 May 2025 — SOU EXTENSION 1 FILED
- 23 May 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Dec 2024 — TEAS DELETE 1(B) BASIS RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT